StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
2666.HK$5.24+1.35%
Fair $5.24+0.0%

2666.HK

Genertec Universal Medical Group Company Limited

Financial Services / Credit ServicesHKSE

$5.24

+0.07 (+1.35%)

Fairly Valued+0.0%Fair Value $5.24Fund rank 28/100 · Data gapFallback financials|
SA 34/D
F-Score: 8/9
High DebtMargin Compression

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 47.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 55/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. Debt-to-Equity ratio is 2.52, above the 2.0 threshold Operating margin has declined for 3 consecutive years
Thesis & Journal · 2666.HKLocal privado en este navegador · Genertec Universal Medical Group Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$10.6B

P/E

4.2x

↓

EV/EBITDA

15.8x

↑

ROE

10.5%

↑

Gross Margin

33.7%

↓

Debt/Equity

2.52

↑
52-Week Range$5
$5$7

TradingView lightweight chart

2666.HK price, volumen y niveles de valoración

Último $5.240Periodo +4.8%
Fair value: $5.240

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.4%

FCF CAGR

+50.2%

FCF margin

32.0%

FCF / Net income

2.17x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $14.94B · net income $2.21B · FCF $4.79B

2022-FY → 2025-FY

Gross margin

33.7%-3.6% pts

Operating margin

21.8%-5.9% pts

Net margin

14.8%-1.4% pts

FCF margin

32.0%+20.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$14.94B$14.94B$13.66B$13.65B$12.07B
Net Income$2.21B$2.21B$2.10B$2.11B$1.96B
EBITDA$3.88B$3.88B$3.56B$3.41B$3.18B
EPS1.081.081.020.990.93
Gross Margin33.7%33.7%33.6%33.5%37.2%
Operating Margin21.8%21.8%22.6%23.7%27.7%
Net Margin14.8%14.8%15.4%15.5%16.2%
Balance Sheet
Debt/Equity2.522.523.003.013.24
Current Ratio2.842.84———
Cash Flow
Free Cash Flow$4.79B$4.79B$-116.8M$4.10B$1.41B
Returns
ROE10.5%10.5%11.2%12.2%12.5%
Valuation
P/E4.164.164.704.315.10
EV/EBITDA15.7815.7817.9117.0618.19
P/B0.500.500.510.510.63
Growth & Yield
Revenue Growth9.3%9.3%0.1%13.1%—
EPS Growth5.9%5.9%3.0%6.5%—
Dividend Yield6.7%6.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-24.5%

fácil

EPS terminal req.

$0.46

Spread vs growth

30.4%

5Y implied EPS CAGR

-12.2%

fácil

EPS terminal req.

$0.56

Spread vs growth

18.1%

10Y implied EPS CAGR

-1.7%

fácil

EPS terminal req.

$0.91

Spread vs growth

7.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +5.9%

Total return

+5.9%

Start / end P/E

5.2x → 4.9x

EPS bridge

1.02 → 1.08

Residual

-0.4%

EPS growth+5.9%
Multiple rerating-6.3%
Dividend+6.7%
Residual / FX / buybacks / cross-term-0.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.